AEterna Zentaris: Top 25 Undervalued Toronto Stock Exchange Stocks (AEZS)
AEterna Zentaris is now ranked among the top 25 undervalued stocks listed on the Toronto Stock Exchange.
- A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
- Valuation methodology provided by Stockcalc (see below)
- Small, micro and nano group market capitalization (<10B)
Stocks in this category are held primarily for capital appreciation and/or dividends.
The Toronto Stock Exchange (TSX) is the largest exchange in Canada and one of the largest in the world. It is home for “senior” well-established equities.
Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
---|---|---|---|---|---|---|---|---|
AXIS | Axis Auto Fin | 0.06 | 0.16 | 0.10 (186.7%) | 32886 | 6.7 | 0.0 | 0.0 |
IVQ-U | Invesque | 0.26 | 0.73 | 0.47 (181.0%) | 1035 | 14.7 | 0.0 | 0.0 |
TMD | Titan Medical | 0.07 | 0.19 | 0.12 (172.1%) | 93624 | 9.0 | 0.0 | 0.0 |
HOT-U | American Hotel Inc Props | 0.46 | 1.14 | 0.68 (148.3%) | 683 | 36.3 | 29.6 | 0.0 |
ORE | Orezone Gold | 0.84 | 1.96 | 1.12 (133.1%) | 146034 | 313.2 | 0.0 | 5.2 |
FOOD | Goodfood Market | 0.26 | 0.60 | 0.34 (131.8%) | 34461 | 19.9 | 0.0 | 0.0 |
VPH | Valeo Pharma | 0.17 | 0.39 | 0.22 (130.6%) | 26210 | 14.6 | 0.0 | 0.0 |
SGLD | Sabre Gold Mines | 0.10 | 0.22 | 0.12 (124.1%) | 39480 | 7.2 | 0.0 | 0.0 |
NVO | Novo Resources | 0.11 | 0.24 | 0.13 (119.4%) | 128613 | 32.7 | 0.0 | 0.0 |
AEZS | AEterna Zentaris | 2.75 | 5.97 | 3.22 (117.0%) | 2894 | 13.4 | 0.0 | 0.0 |
GMTN | Gold Mountain Mining | 0.01 | 0.03 | 0.02 (116.3%) | 574204 | 1.3 | 0.0 | 0.0 |
CFF | Conifex Timber | 0.64 | 1.35 | 0.71 (111.6%) | 13581 | 25.7 | 0.0 | 0.0 |
FURY | Fury Gold Mines | 0.56 | 1.16 | 0.60 (106.5%) | 42773 | 81.5 | 0.0 | 0.0 |
ITE | i3 Energy | 0.18 | 0.37 | 0.19 (104.3%) | 165144 | 219.0 | 7.4 | 3.6 |
LEV | Lion Electric | 1.83 | 3.70 | 1.87 (102.2%) | 448026 | 410.5 | 0.0 | 0.0 |
NCP | Nickel Creek Platinum | 0.01 | 0.03 | 0.01 (99.4%) | 102134 | 7.0 | 0.0 | 0.0 |
SGNL | Signal Gold | 0.09 | 0.18 | 0.09 (99.3%) | 125615 | 22.6 | 0.0 | 0.0 |
IVQ | Invesque | 0.37 | 0.73 | 0.36 (97.4%) | 10262 | 21.0 | 0.0 | 0.0 |
CWL | Caldwell Partners Intl | 0.70 | 1.35 | 0.65 (93.0%) | 7481 | 20.7 | 0.0 | 0.0 |
IAU | i-80 Gold | 1.72 | 3.25 | 1.53 (88.9%) | 711683 | 471.4 | 0.0 | 0.0 |
AVNT | Avant Brands | 0.10 | 0.18 | 0.08 (88.5%) | 167884 | 23.8 | 0.0 | 0.0 |
CJR-B | Corus Entertainment | 0.72 | 1.35 | 0.63 (87.5%) | 247563 | 143.6 | 8.2 | 0.0 |
BLDP | Ballard Power Systems | 3.70 | 6.90 | 3.20 (86.4%) | 743813 | 1105.0 | 0.0 | 0.0 |
BRMI | Boat Rocker Media | 0.90 | 1.65 | 0.75 (83.0%) | 8538 | 50.7 | 0.0 | 0.0 |
SSRM | SSR Mining | 5.41 | 9.81 | 4.40 (81.3%) | 801476 | 1107.5 | 6.3 | 0.0 |
All data provided as of March 31, 2024.
The list is sorted by stocks with the greatest percentage difference between valuation and price.
AEterna Zentaris
AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada.
AEterna Zentaris is listed under AEZS on the Toronto Stock Exchange.
Stockcalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.
Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:
- Discounted Cash Flow (DCF)
- Price & Other Comparables
- Multiples
- Adjusted Book Value (ABV)
- Analyst Consensus
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.